Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Adaptive Trials Guidance For Pediatric Drugs Will Draw On Device Advice

Executive Summary

FDA’s centers may slingshot development work on how best to use control data.

You may also be interested in...

Can Basket Trials Boost Use Of Bayesian Statistics?

Basket trials like NCI-MATCH could show the value of adaptive clinical trial designs based on advanced Bayesian statistics, furthering a goal of the 21st Century Cures draft legislation.

Modifying Clinical Studies Midstream Can Be Done, With Caution, FDA Says

Adaptive device clinical trials, where study is designed in anticipation of midstream changes, are the focus on a new FDA draft guidance. Adaptive trials can reduce the duration and cost of a study without undermining its integrity, but the practice should be applied with caution, FDA says.

Pediatric Studies: FDA Pushes Earlier Dermatitis Trials; Will It Push Others Next?

Advisory committee encourages studies with young children in the disease; emphasis on research as a safety tool could have broader policy implications.

Related Content


Related Companies

Latest News



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts